Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

5,205.00GBp
12:15pm EDT
Price Change (% chg)

-5.00p (-0.10%)
Prev Close
5,210.00p
Open
5,220.00p
Day's High
5,225.00p
Day's Low
5,150.00p
Volume
821,559
Avg. Vol
901,313
52-wk High
5,350.00p
52-wk Low
4,225.00p

RB.L

Chart for RB.L

About

Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries. The Company analyses its revenue based on health, hygiene, home and portfolio brands together with RB Pharmaceuticals and Food. The... (more)

Overall

Beta: 0.61
Market Cap (Mil.): £37,620.45
Shares Outstanding (Mil.): 722.08
Dividend: 60.00
Yield (%): 2.63

Financials

  RB.L Industry Sector
P/E (TTM): 20.10 44.93 34.23
EPS (TTM): 2.59 -- --
ROI: 20.75 108.45 50.31
ROE: 30.69 126.14 58.71
Search Stocks

European shares tip lower on U.S. data, Russia risk

* FTSEurofirst 300 down 0.2 pct, Euro STOXX 50 down 0.1 pct

28 Jul 2014

Reckitt Benckiser to spin off heroin treatment business

LONDON - Reckitt Benckiser plans to spin off its heroin-addiction treatment in the next 12 months as sales slide under pressure from rival copycat versions of the drug. | Video

28 Jul 2014

European shares subdued as investors weigh earnings

LONDON/PARIS, July 28 - European stocks traded flat on Monday, with strong earnings updates from firms like Ryanair and spin-off talk from Reckitt Benckiser balancing concerns over the implications of new international sanctions on Russia.

28 Jul 2014

UK's FTSE propped up by rally in Reckitt shares

LONDON, July 28 - Britain's top equity index crept higher on Monday, supported by solid results at consumer goods company Reckitt Benckiser which offset a slump at Aberdeen Asset Management.

28 Jul 2014

Reckitt helps keep Britain's FTSE afloat after solid update

LONDON - Britain's main equity index was little changed on Monday, helped by solid results from consumer-goods company Reckitt Benckiser and strong data about Chinese corporate profits.

28 Jul 2014

UPDATE 1-Reckitt Benckiser to spin off heroin treatment business

LONDON, July 28 - Reckitt Benckiser plans to spin off its heroin-addiction treatment in the next 12 months as sales slide under pressure from rival copycat versions of the drug.

28 Jul 2014

Reckitt helps keep Britain's FTSE afloat after solid update

* Reckitt Benckiser leads risers after solid update, disposal plan

28 Jul 2014

Reckitt Benckiser has not decided whether to keep pharma stake

LONDON, July 28 - Reckitt Benckiser Group has not decided whether to maintain a stake in its shrinking pharmaceuticals business following a spin-off it expects to complete in the next 12 months.

28 Jul 2014

Reckitt Benckiser to spin off pharma business

LONDON, July 28 - British consumer goods company Reckitt Benckiser Group has decided to spin off its Suboxone pharmaceuticals business in the next 12 months, it said on Monday, ending months of speculation over the shrinking division's future.

28 Jul 2014

Aurelius buys Scholl shoe business from Reckitt Benckiser

FRANKFURT - German private equity firm Aurelius said on Monday it is buying Reckitt Benckiser's Scholl shoe business in its efforts to expand internationally, betting on the brand's growth potential.

21 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks